Q301--662-20-1-146-0003 Anatomic Pathology Decipher Tests: Decipher Prostate Cancer Classifier Biopsy & Decipher Prostate Cancer Classifier Post-Op Test

The Department of Veterans Affairs, Network Contracting Office 21, intends to award a firm-fixed-price, sole-source contract to Decipher Corp for anatomic pathology testing services. The scope of work involves providing the Decipher Prostate Cancer Classifier Biopsy and Post-Op tests, which are proprietary genomic assessments used to predict the probability of metastasis after surgery and evaluate tumor aggressiveness. Physicians at the San Francisco VA Medical Center will utilize these results to determine the likelihood of high-grade disease and long-term prostate cancer mortality to guide clinical diagnoses and treatment decisions for Veteran patients.

This requirement is identified under solicitation number 36C26120Q0010 and is classified under NAICS 621511 for Medical Laboratories and PSC Q301 for Medical Laboratory Testing. The performance period is scheduled to run from April 1, 2020, through March 31, 2023, within the United States. A Justification and Approval for this sole-source acquisition will be posted in accordance with federal regulations.

The pre-solicitation notice was published on March 13, 2020, and contains no associated attachments. Licia Haynie serves as the point of contact for this procurement. As a sole-source intent notice, the government aims to contract directly with Decipher Corp for these specific diagnostic services.